30 March 2020

Johannes Textor, theme Cancer development and immune defense, has been awarded a program grant of 1 million US dollars by The Human Frontier Science Program (HFSP), together with his team members Judith Mandl (McGill University, Montreal, Canada) and Daniel Parisi (Buenos Aires institute of Technology, Argentina). 
 
The T cells of the adaptive immune system are constantly on the move, can enter most tissues, and operate inlarge crowds. Millions of densely packed T cells roam the lymphatic organs  in search of foreign antigen while activated T cells divide vigorously and flock to tissues where they mount local immune responses to pathogens or cancer cells.
 
The HFSP project combines expertise in immunology, computational biology, and pedestrian dynamics to shed light how T cell crowds remain motile with such remarkable efficiency in many conditions and what it would take to disrupt their smooth flow
 
HFSP grants are highly competitive awards intended for basic research at the frontier of human knowledge. They are open to applicants from all nations, and awardees are selected through a rigorous year-long review process. From more than 700 proposals that were initially submitted by scientists based in more than 50 different countries, only the top 4% were funded, and Johannes Textor's propasal was ranked third overall. Johannes Textor was the only scientist from a Dutch instutition to be selected.

Related news items


The new front line: big data podcast

22 May 2020

What role do big data and technology play in the fight against corona? What data can help save lives? How do you ensure that your personal health data is used safely? Among others, Peter-Bram 't Hoen explains.

read more

OARSI Basic Science Award for Peter van der Kraan

22 May 2020

Purpose of this Basic Science Award of the Osteoarthritis Research Society International (OARSI) is to stimulate fundamental research in the field of osteoarthritis.

read more

Evaluation of an AI system for detection of COVID-19 on Chest X-Ray images

22 May 2020

In the journal Radiology RIHS researcher Keelin Murphy described how an artificial intelligence system (CAD4COVID-XRay) can identify characteristics of COVID-19 on chest x-rays with performance comparable to six independent radiologists.

read more

First clinical trial with genetically modified malaria vaccine completed

22 May 2020

In an innovative study, Radboudumc and LUMC jointly tested a candidate vaccine based on a genetically weakened malaria parasite. The results of this clinical trial, published in Science Translational Medicine, show that the vaccine is safe and elicits a defense response against a malaria infection.

read more

New step in the development of a vaccine against malaria

22 May 2020

A new vaccine based on rodent malaria parasites achieved a 95% reduction in infection of the liver in humans. An international consortium publishes the results in Science Translational Medicine.

read more

Retirement of RIMLS Laboratory Assistant Nelly Mulders-Langen

19 May 2020

After more than 45 years, Nelly said goodbye to "her" Radboudumc. We are going to miss her dedication and collegiality, but we wish her al the best for the future in good health. 

read more